TherapeuticsMD, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
TherapeuticsMD, Inc. (TXMD) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $28.00 thousand as of 2025-12-31, per its 10-K/A filed 2026-04-01.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-04-01
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $28.00K.
- 2024-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $81.00K.
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $300.00K.
- 2023-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $400.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $28.00K 10-K/A · filed 2026-04-01 |
| 2024-06-30 | $81.00K 10-Q · filed 2024-08-12 |
| 2023-12-31 | $300.00K 10-K · filed 2024-03-29 |
| 2023-09-30 | $400.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $500.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $800.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $700.00K 10-K · filed 2023-04-07 |
| 2022-09-30 | $6.10M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $12.20M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $17.80M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $16.20M 10-K · filed 2022-03-23 |
| 2021-09-30 | $22.70M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $10.00M 10-Q · filed 2021-08-04 |
| 2020-12-31 | $5.24M 10-K · filed 2021-03-04 |
| 2020-09-30 | $6.50M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $7.70M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $9.80M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $11.46M 10-K · filed 2020-02-24 |
| 2019-09-30 | $13.47M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $11.61M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $12.94M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $12.18M 10-K · filed 2019-02-27 |
| 2018-09-30 | $14.20M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $13.82M 10-Q · filed 2018-07-30 |
| 2018-03-31 | $15.07M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $10.60M 10-K · filed 2018-02-23 |
| 2017-09-30 | $12.42M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $14.37M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $16.17M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $10.67M 10-K · filed 2017-02-28 |
| 2015-12-31 | $19.80M 10-K · filed 2016-02-26 |
| 2015-09-30 | $5.59M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $7.11M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $7.21M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $5.16M 10-K · filed 2015-03-12 |
| 2014-09-30 | $6.83M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $6.62M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $6.11M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $3.92M 10-K · filed 2015-03-12 |
| 2012-12-31 | $4.39M 10-K · filed 2015-03-12 |
| 2011-12-31 | $244.00K 10-K · filed 2014-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |